Bausch Health Companies | VRX - Ebit



Bausch Health Companies reported $605M in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Amgen USD 2.26B 1.34B Jun/2025
ANI Pharmaceuticals USD 15.17M 10.3M Jun/2025
Aurora Cannabis CAD -17609000 54.46M Jun/2025
Bausch Health Companies USD 605M 18M Jun/2025
Biogen USD 816.6M 233.8M Jun/2025
Bristol-Myers Squibb USD 2.26B 1.92B Jun/2025
Canopy Growth CAD -31497000 7.68M Jun/2025
Corcept Therapeutics USD 26.67M 23.26M Jun/2025
Danaher USD 760M 939M Jun/2025
Drreddys Laboratories INR 19.88B 1.86B Jun/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
Gilead Sciences USD 2.7B 189M Jun/2025
Novo Nordisk 34.08B 4.71B Jun/2025
Pacira USD 10.23M 2.21M Jun/2025
Perrigo USD 55.6M 91M Jun/2025
Prestige Brands USD 71.76M 29.14M Jun/2025
Supernus Pharmaceuticals USD 12.14M 14.74M Jun/2025
Vertex Pharmaceuticals USD 1.15B 420.8M Jun/2025
Zoetis USD 1.02B 106M Jun/2025